prescription digital therapeutics

Pear Therapeutics loses 97% of its market capitalization since 2021, explores strategic alternatives

by Leave a Comment

Source: Google Finance

Pear Ther­a­peu­tics explor­ing sale, oth­er ‘strate­gic alter­na­tives’ (Mobi­Health News):

Pre­scrip­tion dig­i­tal ther­a­peu­tics com­pa­ny Pear Ther­a­peu­tics is explor­ing “strate­gic alter­na­tives,” includ­ing a pos­si­ble com­pa­ny sale, merg­er or acquisition.

In a press release, the com­pa­ny said it hired a finan­cial advi­sor to look into actions that could “max­i­mize share­hold­er val­ue.” That includes a poten­tial sale, M&A, divesti­ture of assets, licens­ing or oth­er strate­gic trans­ac­tions. It may also seek addi­tion­al financ­ing. [Read more…] about Pear Ther­a­peu­tics los­es 97% of its mar­ket cap­i­tal­iza­tion since 2021, explores strate­gic alternatives

Pear Therapeutics raises $175M and goes public via SPAC deal raising the profile of prescription digital therapeutics

by

Dig­i­tal health firm Pear goes pub­lic, rais­ing $175 mil­lion (phar­mafo­rum):

Pear will make its debut on the exchange today after com­bin­ing with Thim­ble Point – a spe­cial pur­pose acqui­si­tion com­pa­ny (SPAC) – in a deal that side­stepped the con­ven­tion­al ini­tial pub­lic offer­ing (IPO) route and has pro­pelled its val­u­a­tion to around $1.6 bil­lion … Pear spe­cialis­es in pre­scrip­tion dig­i­tal ther­a­peu­tics (DTx) based on cog­ni­tive behav­iour­al ther­a­py (CBT) tech­niques that can deliv­ered remote­ly to [patients via a dig­i­tal device. It has three apps approved by the FDA, includ­ing reSET and reSET‑O for peo­ple liv­ing with sub­stance and opi­oid use dis­or­ders, respec­tive­ly, and a tool for chron­ic insom­ni­acs called Som­ryst. [Read more…] about Pear Ther­a­peu­tics rais­es $175M and goes pub­lic via SPAC deal rais­ing the pro­file of pre­scrip­tion dig­i­tal therapeutics

Integrating music, movement and stroke rehabilitation, MedRhythms raises $25M to develop and commercialize digital therapeutic

by

MedRhythms rais­es 25m to get patients back in tune after a stroke (TechCrunch):

MedRhythms secured $25 mil­lion in Series B fund­ing to advance its dig­i­tal ther­a­py plat­form aimed at mea­sur­ing and improv­ing someone’s abil­i­ty to walk after they have expe­ri­enced a neu­ro­log­ic injury or dis­ease … Com­pa­ny co-founder and CEO Bri­an Har­ris was a neu­ro­log­ic music fel­low at Spauld­ing Reha­bil­i­ta­tion Hos­pi­tal in Boston, treat­ing peo­ple with stroke and brain deficits with music. He began get­ting ques­tions from patients and fam­i­lies on how they could access sim­i­lar care out­side of the hos­pi­tal. Not see­ing a suit­able alter­na­tive, he start­ed MedRhythms with entre­pre­neur Owen McCarthy in 2016. [Read more…] about Inte­grat­ing music, move­ment and stroke reha­bil­i­ta­tion, MedRhythms rais­es $25M to devel­op and com­mer­cial­ize dig­i­tal therapeutic

Prescription software firm Pear Therapeutics to go public via $1.6 billion SPAC deal, harnessing 3 FDA-authorized products and 14 candidates

by

Pear Ther­a­peu­tics to Go Pub­lic in Rough­ly $1.6 Bil­lion SPAC Deal (The Wall Street Journal):

Med­ical tech­nol­o­gy com­pa­ny Pear Ther­a­peu­tics Inc. has agreed to go pub­lic by merg­ing with a blank-check com­pa­ny with ties to the Pritzk­er Vlock Fam­i­ly Office, bet­ting on the grow­ing role of pre­scrip­tion dig­i­tal therapeutics.

The pro­posed merg­er would give the com­bined com­pa­ny a pro for­ma equi­ty val­ue of about $1.6 bil­lion. [Read more…] about Pre­scrip­tion soft­ware firm Pear Ther­a­peu­tics to go pub­lic via $1.6 bil­lion SPAC deal, har­ness­ing 3 FDA-autho­rized prod­ucts and 14 candidates

Akili Interactive Labs raises $160M in equity and debt to transform cognitive healthcare via prescription videogame treatments

by

Akili rais­es $110m to build its dig­i­tal ther­a­peu­tics pipeline (phar­mafo­rum):

Endeav­or­Rx became the first and so far only approved pre­scrip­tion video game treat­ment in the US when it was cleared by the FDA last year to treat atten­tion-deficit hyper­ac­tiv­i­ty dis­or­der (ADHD), and has also been giv­en a green light in Europe. [Read more…] about Akili Inter­ac­tive Labs rais­es $160M in equi­ty and debt to trans­form cog­ni­tive health­care via pre­scrip­tion videogame treatments

Ohio joins Indiana and Kentucky in funding Pear Therapeutics’ digital addiction treatments

by

Ohio is third state to fund Pear’s dig­i­tal ther­a­peu­tics to tack­le addic­tion (phar­mafo­rum):

The com­pa­ny has been push­ing for more reim­burse­ment of its three mar­ket­ed DTx prod­ucts in the US fol­low­ing a first FDA approval in 2017.

Pear said that the Ohio Depart­ment of Men­tal Health and Addic­tion Ser­vices (OhioMHAS) and Recov­ery­Ohio are pro­vid­ing access to Pear’s FDA-approved DTx reSET and reSET‑O, for treat­ment of sub­stance use dis­or­der and opi­oid use dis­or­ders, respec­tive­ly. [Read more…] about Ohio joins Indi­ana and Ken­tucky in fund­ing Pear Ther­a­peu­tics’ dig­i­tal addic­tion treatments